바이오인

 

 

The European Council and the European Parliament have recognised the importance of life sciences and biotechnology, and the Commission has put forward an action plan to address the challenges and opportunities involved. This Strategy on Life Sciences and Biotechnology , adopted by the Commission in 2002, proposed a 30 point action plan involving the Commission, the other European Institutions and other stakeholders. It runs until 2010.

 

The scope of the Strategy - the first of its kind at EU level - was originally very broad, to cover all possible relevant policy issues and facilitate the uptake of the technology in a wide range of different sectors. Action was proposed under four headings: harvesting the potential (research, access to capital etc), promoting governance (social dialogue, ethical scrutiny etc), answering global challenges (encourage scientific cooperation with developing countries etc) and ensuring coherence between the full range of policies concerned.

 

The implementation of the Strategy is now at its mid point. It is time to evaluate the progress achieved since 2002 and update the Strategy, to reflect new analysis of how this fast-moving sector could contribute to EU policies . This is the purpose of this Communication and the annexed Staff Working Paper.

 

The doccument includes the following detailsof the Reed Life Sciences and Biotechnology Action Plan.